The stock of Canopy Growth Corporation (NASDAQ:CGC) last traded at $1.05, unchanged from the previous session.
Data from the available sources indicates that Canopy Growth Corporation (NASDAQ:CGC) is covered by 16 analysts. The consensus rating among analysts is ‘Underweight’. As we calculate the median target price by taking the range between a high of $6.54 and a low of $0.74, we find $1.56. Given the previous closing price of $1.05, this indicates a potential upside of 48.57 percent. CGC stock price is now -32.76% away from the 50-day moving average and -60.24% away from the 200-day moving average. The market capitalization of the company currently stands at $547.05M.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
Sponsored
In total, 7 analysts have assigned it a hold rating, and 2 have given it a buy rating. Brokers who have rated the stock have averaged $2.02 as their price target over the next twelve months.
On November 02, 2022, Bernstein recently initiated its ‘Underperform’ rating on the stock quoting a target price of $1.50, while ‘Canaccord Genuity’ rates the stock as ‘Hold’.
In other news, Lazzarato David Angelo, Director sold 3,733 shares of the company’s stock on Dec 28. The stock was sold for $11,087 at an average price of $2.97. Upon completion of the transaction, the Director now directly owns 19,679 shares in the company, valued at $20662.95. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 28, Director Yanofsky Theresa sold 3,717 shares of the business’s stock. A total of $11,039 was realized by selling the stock at an average price of $2.97. This leaves the insider owning 25,137 shares of the company worth $26393.85. A total of 33.53% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in CGC stock. A new stake in Canopy Growth Corporation shares was purchased by ETF MANAGERS GROUP, LLC during the first quarter worth $8,512,000. AXS INVESTMENTS LLC invested $428,000 in shares of CGC during the first quarter. In the first quarter, CENTERBOOK PARTNERS LP acquired a new stake in Canopy Growth Corporation valued at approximately $197,000. BNP PARIBAS ARBITRAGE, SNC acquired a new stake in CGC for approximately $105,000. SCULPTOR CAPITAL LP purchased a new stake in CGC valued at around $83,000 in the second quarter. In total, there are 438 active investors with 14.21% ownership of the company’s stock.
With an opening price of $1.0500 on Thursday morning, Canopy Growth Corporation (NASDAQ: CGC) set off the trading day. During the past 12 months, Canopy Growth Corporation has had a low of $1.02 and a high of $6.00. The fifty day moving average price for CGC is $1.5380 and a two-hundred day moving average price translates $2.6314 for the stock.
The latest earnings results from Canopy Growth Corporation (NASDAQ: CGC) was released for Dec, 2022. According to the Drug Manufacturers – Specialty & Generic Company, earnings per share came in at -$0.4, missing analysts’ expectations of -$0.17 by -0.23. This compares to -$0.23 EPS in the same period last year. The company reported revenue of $74.62 million for the quarter, compared to $111.86 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -33.29 percent. For the current quarter, analysts expect CGC to generate $72.46M in revenue.
Canopy Growth Corporation(CGC) Company Profile
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company’s products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.
